Citalopram EP Impurity F, with the CAS number 1644389-68-3, is a chemical compound associated with the pharmaceutical drug citalopram, which is primarily used as an antidepressant. As an impurity, it is typically a byproduct of the synthesis of citalopram and may arise during the manufacturing process. The characteristics of this compound include its molecular structure, which is related to the core structure of citalopram, and it may exhibit similar functional groups, influencing its chemical behavior. Impurities like Citalopram EP Impurity F are often characterized by their solubility in various solvents, stability under different conditions, and potential biological activity. Regulatory agencies monitor such impurities to ensure they remain within acceptable limits in pharmaceutical formulations, as they can affect the safety and efficacy of the final product. Analytical techniques such as HPLC (High-Performance Liquid Chromatography) and NMR (Nuclear Magnetic Resonance) spectroscopy are commonly employed to identify and quantify impurities in drug substances.

Citalopram EP Impurity F

1644389-68-3: Citalopram EP Impurity F, with the CAS number 1644389-68-3, is a chemical compound associated with the pharmaceutical drug citalopram, which is primarily used as an antidepressant. As an impurity, it is typically a byproduct of the synthesis of citalopram and may arise during the manufacturing process. The characteristics of this compound include its molecular structure, which is related to the core structure of citalopram, and it may exhibit similar functional groups, influencing its chemical behavior. Impurities like Citalopram EP Impurity F are often characterized by their solubility in various solvents, stability under different conditions, and potential biological activity. Regulatory agencies monitor such impurities to ensure they remain within acceptable limits in pharmaceutical formulations, as they can affect the safety and efficacy of the final product. Analytical techniques such as HPLC (High-Performance Liquid Chromatography) and NMR (Nuclear Magnetic Resonance) spectroscopy are commonly employed to identify and quantify impurities in drug substances.

CAS 1644389-68-3

Citalopram EP Impurity F

Citalopram EP Impurity F HCl (Citalopram USP Related Compound H HCl)

Ref: 4Z-C-0940